In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope
RSS SUMMARY · AGGREGATED FROM FORBES
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.
Continue Reading
The full story continues on Forbes.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
FORBES
Tech
On World Ocean Day, The Islands Of Tahiti Show That Conservation And Tourism Go Hand In Hand
FORBES·4h ago·3 min read
Tech
Streaming’s Best New Show Has A Perfect 100% Rotten Tomatoes Score
FORBES·1h ago·3 min read
Tech
The Hidden Intake Gap: Why ABA Referral Conversion Fails Before The First Visit
FORBES·2h ago·3 min read
Tech
Here’s Everything Coming To Destiny 2’s Final June 9 Update
FORBES·1h ago·3 min read
Related
On this beat
Tech
On World Ocean Day, The Islands Of Tahiti Show That Conservation And Tourism Go Hand In Hand
FORBES·4h ago·3 min read
Tech
Eero’s Pro 6E routers are down to their cheapest price yet in 2026
THE VERGE·1h ago·3 min read
Tech
Apple pulls Russia’s state-backed MAX app from App Store over sanctions compliance
TECHRADAR·1h ago·3 min read
Tech
I tried TikTok’s most viral hair hacks —what’s actually worth it
TECHRADAR·57m ago·3 min read